Multimodal and three-dimensional imaging of prostate cancer.
暂无分享,去创建一个
Zhenghong Lee | Martin Resnick | M. Resnick | G. MacLennan | D. B. Sodee | Z. Lee | D Bruce Sodee | Gregory T Maclennan | D. Sodee
[1] Guido Gerig,et al. Three-dimensional multi-scale line filter for segmentation and visualization of curvilinear structures in medical images , 1998, Medical Image Anal..
[2] J. Schnitzer. Vascular targeting as a strategy for cancer therapy. , 1998, The New England journal of medicine.
[3] Fred L. Bookstein,et al. Principal Warps: Thin-Plate Splines and the Decomposition of Deformations , 1989, IEEE Trans. Pattern Anal. Mach. Intell..
[4] S. Cherry,et al. Combining anatomy and function: the path to true image fusion , 2001, European Radiology.
[5] A. Belldegrun,et al. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer. , 1999, The Journal of urology.
[6] C A Pelizzari,et al. Using vascular structure for CT-SPECT registration in the pelvis. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] M. Ercan,et al. Radiopharmaceuticals for the visualization of infectious and inflammatory lesions. , 2000, Current pharmaceutical design.
[8] J. McNeal,et al. Patterns of spread of adenocarcinoma in the prostate as related to cancer volume , 2001, The Prostate.
[9] A. Boynton,et al. Monoclonal antibody 7E11.C5 staining of viable LNCaP cells , 1997, The Prostate.
[10] H. Dvorak,et al. Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. , 1991, Cancer cells.
[11] S. Vallabhajosula,et al. Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[12] Taylor Murray,et al. Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.
[13] D. Bostwick,et al. Current evaluation of the tissue localization and diagnostic utility of prostate specific membrane antigen , 1998, Cancer.
[14] J. Papadimitriou,et al. Progressive increase of apoptosis in prostatic intraepithelial neoplasia and carcinoma: comparison between in situ end-labeling of fragmented DNA and detection by routine hematoxylin-eosin staining. , 1997, Archives of pathology & laboratory medicine.
[15] David L Wilson,et al. Automatic registration of MR and SPECT images for treatment planning in prostate cancer. , 2003, Academic radiology.
[16] Zhenghong Lee,et al. PET imaging-based evaluation of aerosol drugs and their delivery devices: nasal and pulmonary studies , 2002, IEEE Transactions on Medical Imaging.
[17] C. Cordon-Cardo,et al. Prostate-specific membrane antigen expression in normal and malignant human tissues. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[18] Marc Levoy,et al. Display of surfaces from volume data , 1988, IEEE Computer Graphics and Applications.
[19] Carl-Fredrik Westin,et al. Tissue Classification Based on 3D Local Intensity Structures for Volume Rendering , 2000, IEEE Trans. Vis. Comput. Graph..
[20] George L. Wright,et al. Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluids , 1995, International journal of cancer.
[21] G. Bakale,et al. Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers. , 2000, Urology.
[22] S. Rosenthal,et al. Monoclonal antibody imaging of occult prostate cancer in patients with elevated prostate-specific antigen. Positron emission tomography and biopsy correlation. , 1996, Clinical nuclear medicine.